Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -20 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 385 |
| Other Investing Activity | 0 | -60 | -30 | -18 | -14 |
| Investing Cash Flow | $N/A | $-80 | $-30 | $-18 | $371 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8 | N/A | N/A | 1,187 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -70 | N/A |
| Financing Cash Flow | $8 | $N/A | $N/A | $1,117 | $N/A |
| Exchange Rate Effect | 12 | -16 | -19 | -36 | -28 |
| Beginning Cash Position | 598 | 969 | 1,279 | 788 | 343 |
| End Cash Position | 325 | 598 | 969 | 1,279 | 788 |
| Net Cash Flow | $-285 | $-356 | $-290 | $527 | $473 |
| Free Cash Flow | |||||
| Capital Expenditure | N/A | -80 | -30 | -18 | -14 |
| Free Cash Flow | 0 | -80 | -30 | -18 | -14 |